Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results
Authors
Keywords
-
Journal
Cancers
Volume 5, Issue 4, Pages 529-549
Publisher
MDPI AG
Online
2013-05-11
DOI
10.3390/cancers5020529
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Dedifferentiated Liposarcoma Xenograft Models Reveal PTEN Down-Regulation as a Malignant Signature and Response to PI3K Pathway Inhibition
- (2013) Kathleen B. Smith et al. AMERICAN JOURNAL OF PATHOLOGY
- Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study
- (2013) B. L. Samuels et al. ANNALS OF ONCOLOGY
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- Lymphocyte Composition and Distribution in Inflammatory, Well-differentiated Retroperitoneal Liposarcoma
- (2012) William W. Tseng et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Advanced pleomorphic liposarcomas: clinical outcome and impact of chemotherapy
- (2012) A. Italiano et al. ANNALS OF ONCOLOGY
- A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies
- (2012) Michael J. Pishvaian et al. CANCER
- NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma
- (2012) Seth M. Pollack et al. CANCER
- Phase I study of nelfinavir in liposarcoma
- (2012) Janet Pan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates Doxorubicin Efficacy in Advanced Sarcomas: Preclinical Investigations and Results of a Phase I Dose-Escalation Clinical Trial
- (2012) J. J. Luke et al. CLINICAL CANCER RESEARCH
- Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
- (2012) Isabelle Ray-Coquard et al. LANCET ONCOLOGY
- NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis
- (2012) Jin-Ping Lai et al. MODERN PATHOLOGY
- The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas
- (2012) Jessica A Hemminger et al. MODERN PATHOLOGY
- A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regions
- (2012) Florence Pedeutour et al. VIRCHOWS ARCHIV
- Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival
- (2011) A. Italiano et al. ANNALS OF ONCOLOGY
- Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
- (2011) A. Gronchi et al. ANNALS OF ONCOLOGY
- Diagnosis, Management, and Outcome of Patients with Dedifferentiated Liposarcoma Systemic Metastasis
- (2011) Markus P. Ghadimi et al. ANNALS OF SURGICAL ONCOLOGY
- Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)
- (2011) G K Schwartz et al. BRITISH JOURNAL OF CANCER
- Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas
- (2011) Margaret von Mehren et al. CANCER
- Pleomorphic liposarcoma
- (2011) Markus P. Ghadimi et al. CANCER
- Nelfinavir Induces Liposarcoma Apoptosis through Inhibition of Regulated Intramembrane Proteolysis of SREBP-1 and ATF6
- (2011) M. Guan et al. CLINICAL CANCER RESEARCH
- Update on Liposarcoma: A review for cytopathologists
- (2011) Leslie G. Dodd DIAGNOSTIC CYTOPATHOLOGY
- Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents
- (2011) S. Uboldi et al. INTERNATIONAL JOURNAL OF CANCER
- Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is highly expressed in liposarcoma and promotes migration and proliferation
- (2011) Kay-Dietrich Wagner et al. JOURNAL OF PATHOLOGY
- Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
- (2011) Patrick Schöffski et al. LANCET ONCOLOGY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Establishment and characterization of a novel dedifferentiated liposarcoma cell line, NDDLS-1
- (2011) Takashi Ariizumi et al. PATHOLOGY INTERNATIONAL
- Aberrant AKT activation drives well-differentiated liposarcoma
- (2011) A. Gutierrez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years
- (2010) N. Penel et al. ANNALS OF ONCOLOGY
- Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
- (2010) G. Germano et al. CANCER RESEARCH
- Trabectedin therapy for sarcomas
- (2010) Paolo G Casali et al. CURRENT OPINION IN ONCOLOGY
- New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort
- (2010) Aviad Hoffman et al. DRUG RESISTANCE UPDATES
- Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: Leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma
- (2010) S. Tariq Mahmood et al. INTERNATIONAL JOURNAL OF CANCER
- Multifocal Myxoid Liposarcoma—Metastasis or Second Primary Tumor?
- (2010) Ronald de Vreeze et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors
- (2010) Tingsheng Peng et al. LABORATORY INVESTIGATION
- Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
- (2010) Jordi Barretina et al. NATURE GENETICS
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series
- (2009) F. Grosso et al. ANNALS OF ONCOLOGY
- Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience
- (2009) Ronald S. A. de Vreeze et al. ANNALS OF SURGICAL ONCOLOGY
- Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas
- (2009) Suzanne George et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
- (2009) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
- (2009) Robert G. Maki et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
- (2009) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors
- (2009) C. Forni et al. MOLECULAR CANCER THERAPEUTICS
- Resectable Well-Differentiated versus Dedifferentiated Liposarcomas: Two Different Diseases Possibly Requiring Different Treatment Approaches
- (2008) G. Lahat et al. ANNALS OF SURGICAL ONCOLOGY
- Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis
- (2008) Ronald SA de Vreeze et al. MODERN PATHOLOGY
- Drug development from marine natural products
- (2008) Tadeusz F. Molinski et al. NATURE REVIEWS DRUG DISCOVERY
- Excellent Local Control Rates and Distinctive Patterns of Failure in Myxoid Liposarcoma Treated With Conservation Surgery and Radiotherapy
- (2007) B. Ashleigh Guadagnolo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More